drugset / Trial / NCT01586975

Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

NCT01586975

Phase 2/3 Completed 93 enrolled Northwestern University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if PFA results correlate with ischemic event outcomes as well as bleeding complications. Hypothesis is antiplatelet agents will be more efficacious if they are administered in a dose-adjusted manner using PFA results as a guide.

Timeline

Start
2007-07
Primary completion
2010-04
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg
Comparator Aspirin Small molecule 300 mg
Comparator Clopidogrel Small molecule 75 mg